These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 19954644)
21. Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia. Luo JM; Yoshida H; Komura S; Ohishi N; Pan L; Shigeno K; Hanamura I; Miura K; Iida S; Ueda R; Naoe T; Akao Y; Ohno R; Ohnishi K Leukemia; 2003 Jan; 17(1):1-8. PubMed ID: 12529653 [TBL] [Abstract][Full Text] [Related]
22. [Effects of transfected pIRES-p21(waf1)-p27(kip1) gene on the duplication of centrosomes and the proliferation of breast cancer cell line MCF-7]. Jiang DD; Li FN; Liu XP Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(46):3295-8. PubMed ID: 20193371 [TBL] [Abstract][Full Text] [Related]
23. Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function. Pilon-Thomas S; Nelson N; Vohra N; Jerald M; Pendleton L; Szekeres K; Ghansah T PLoS One; 2011; 6(11):e27729. PubMed ID: 22132131 [TBL] [Abstract][Full Text] [Related]
24. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387 [TBL] [Abstract][Full Text] [Related]
25. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels. Morishita D; Katayama R; Sekimizu K; Tsuruo T; Fujita N Cancer Res; 2008 Jul; 68(13):5076-85. PubMed ID: 18593906 [TBL] [Abstract][Full Text] [Related]
26. Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytes. Wain CM; Westwick J; Ward SG Cell Signal; 2005 Oct; 17(10):1194-202. PubMed ID: 16038794 [TBL] [Abstract][Full Text] [Related]
27. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma. Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656 [TBL] [Abstract][Full Text] [Related]
28. Inducible p27(Kip1) expression inhibits proliferation of K562 cells and protects against apoptosis induction by proteasome inhibitors. Drexler HC; Pebler S Cell Death Differ; 2003 Mar; 10(3):290-301. PubMed ID: 12700629 [TBL] [Abstract][Full Text] [Related]
29. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression. Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587 [TBL] [Abstract][Full Text] [Related]
30. [p21(WAF1) Gene Transfection Inhibits Proliferation of Leukemia Cell Line K562]. Yang H; Wang SW; Yin HJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2001 Jun; 9(2):115-118. PubMed ID: 12578615 [TBL] [Abstract][Full Text] [Related]
31. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells. Wu SH; Lu C; Dong L; Zhou GP; He ZG; Chen ZQ Kidney Int; 2005 Jul; 68(1):35-46. PubMed ID: 15954894 [TBL] [Abstract][Full Text] [Related]
32. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway. Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813 [TBL] [Abstract][Full Text] [Related]
33. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650 [TBL] [Abstract][Full Text] [Related]
34. SHIP-mediated inhibition of K562 erythroid differentiation requires an intact catalytic domain and Shc binding site. Siegel J; Li Y; Whyte P Oncogene; 1999 Nov; 18(50):7135-48. PubMed ID: 10597315 [TBL] [Abstract][Full Text] [Related]
35. [Regulatory effect of ginsenoside Rh2 on HDAC1/2 activity and cyclin in human erythroleukemia K562 cells]. Xia J; Chen D; Zuo G; Wei Q; You Z; Li D; Liu Z; Li J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1062-6. PubMed ID: 25270209 [TBL] [Abstract][Full Text] [Related]
36. Gene transfer of SHIP-1 inhibits proliferation of juvenile myelomonocytic leukemia cells carrying KRAS2 or PTPN11 mutations. Metzner A; Horstmann MA; Fehse B; Ortmeyer G; Niemeyer CM; Stocking C; Mayr GW; Jücker M Gene Ther; 2007 Apr; 14(8):699-703. PubMed ID: 17268534 [TBL] [Abstract][Full Text] [Related]
37. [p21(WAF1) transfection decreases sensitivity of K562 cells to VP-16]. Yang H; Wang SW; Yin HJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):31-4. PubMed ID: 12513833 [TBL] [Abstract][Full Text] [Related]
38. [The role of PTEN-FAK signaling pathway in metastasis and invasive ability of leukemia cells]. Cheng ZY; Guo XL; Li SH; Wang SY; Yang XY; Xue F; Wen SP; Pan L Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):115-20. PubMed ID: 19563023 [TBL] [Abstract][Full Text] [Related]
39. Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT. Mirza AM; Gysin S; Malek N; Nakayama K; Roberts JM; McMahon M Mol Cell Biol; 2004 Dec; 24(24):10868-81. PubMed ID: 15572689 [TBL] [Abstract][Full Text] [Related]
40. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Viglietto G; Motti ML; Bruni P; Melillo RM; D'Alessio A; Califano D; Vinci F; Chiappetta G; Tsichlis P; Bellacosa A; Fusco A; Santoro M Nat Med; 2002 Oct; 8(10):1136-44. PubMed ID: 12244303 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]